Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Blerim Marovca
Observed name:
B. Marovca
Institution:
University Children's Hospital Zurich
Observed institution:
University Children's Hospital Zurich
ORCID:
0000-0002-1874-3203
Observed ORCID:
0000-0002-1874-3203
OpenAlex ID:
A5025256663
Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
2015
·
Ute Fischer
, Michael Forster
, et al.
·
Nature Genetics
·
284
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
2017
·
Viktoras Frismantas
, Maria Pamela Dobay
, et al.
·
Blood
·
283
PDF
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
2016
·
Scott McComb
, Júlia Aguadé-Gorgorió
, et al.
·
Science Translational Medicine
·
123
The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability
2019
·
Yun Huang
, Brice Mouttet
, et al.
·
Cancer Cell
·
63
PDF
PDX models recapitulate the genetic and epigenetic landscape of pediatric T‐cell leukemia
2018
·
Paulina Richter‐Pechańska
, Joachim B Kunz
, et al.
·
EMBO Molecular Medicine
·
53
PDF
Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support
2014
·
Jeannette Boutter
, Yun Huang
, et al.
·
Oncotarget
·
40
PDF
LRH‐1/NR5A2 interacts with the glucocorticoid receptor to regulate glucocorticoid resistance
2022
·
Svenja Michalek
, Thomas Goj
, et al.
·
EMBO Reports
·
19
PDF
TNFR2 is required for RIP1-dependent cell death in human leukemia
2020
·
Júlia Aguadé-Gorgorió
, Scott McComb
, et al.
·
Blood Advances
·
16
PDF
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL
2020
·
Beat Bornhauser
, Gunnar Cario
, et al.
·
Blood Advances
·
12
PDF
B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow
2022
·
Malwine J. Barz
, Lena Behrmann
, et al.
·
Haematologica
·
11
PDF
Repurposing anthelmintic agents to eradicate resistant leukemia
2020
·
Caterina Mezzatesta
, Liridon Abduli
, et al.
·
Blood Cancer Journal
·
10
PDF
Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9
2020
·
Yun Huang
, Blerim Marovca
, et al.
·
HemaSphere
·
5
Drug Response Profiling to Identify Selective Pharmacological Activity in Drug Resistant ALL
2015
·
Viktoras Frismantas
, Maria Pamela Dobay
, et al.
·
Blood
·
2
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
2015
·
Ute Fischer
, Michael Forster
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
·
1
P330: Proteomic Profiling Uncovers Therapeutic Vulnerabilities for Tcf3 Translocated B-cell Acute Lymphoblastic Leukemias
2023
·
Rebecca Hasselmann
, Lena Blümel
, et al.
·
HemaSphere
S128 Bcp‐ and T‐all Cells Hide in Distinct Niches of the Bone Marrow
2019
·
D. Capron
, G. Zuchtriegel
, et al.
·
HemaSphere
TCF3-Hlf Hijacks ERG to Activate Leukemia-Critical Super-Enhancers in t(17;19) Leukemia
2017
·
Yun Huang
, Brice Mouttet
, et al.
·
Blood
Activation of Simultaneous Apoptosis and Necroptosis to Eradicate Drug Resistant Leukemia
2015
·
Scott McComb
, Julia Aguadé-Gorgorió
, et al.
·
Blood
Abstract 493: Drug response profiling to inform individualized treatment approaches in high risk leukemia
2015
·
Viktoras Frismantas
, Anna Rinaldi
, et al.
·
Cancer Research
Genomic and Drug Response Profiling of Fatal TCF3-HLF-Positive Pediatric Acute Lymphoblastic Leukaemia Identifies Recurrent Mutation Patterns and Novel Therapeutic Options
2015
·
J. -P. Bourquin
, U. Fischer
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Show more works
View as search
Works count:
20
Citation count:
922
H-index:
10
I10-index:
11
Year
Topic
Type